Target intelligence / Profile preview

Disks large-associated protein 1 (DLGAP1)

Target
DLGAP1
Molecular classification
Other (Postsynaptic scaffold protein)
01

Overview

Disks large-associated protein 1 (DLGAP1) is a major postsynaptic scaffold protein highly enriched in the brain’s synaptosomal fraction and localized at the postsynaptic density (PSD) of glutamatergic neurons. DLGAP1 links core synaptic scaffolds such as the DLG/PSD-95 and SHANK families, facilitating the assembly of protein supercomplexes that organize synaptic signaling and plasticity. Genetic variants in DLGAP1 are associated with schizophrenia, autism spectrum disorder, and obsessive-compulsive disorder, with evidence suggesting that loss of function impairs PSD organization and sociability in animal models. DLGAP1's role is structural and regulatory within the synapse, forming connections between scaffolding proteins but not acting as a receptor or enzyme. No known drugs currently target DLGAP1 directly; rather, its dysfunction contributes to risk of complex brain diseases.

Other names
DLGAP1DAP-1GKAPSAPAP1hGKAPguanylate kinase-associated proteinPSD-95/SAP90-binding protein 1SAP90/PSD-95-associated protein 1DLGAP1ADLGAP1Bdiscs large homolog associated protein 1
02

Mechanism of action

Not applicable; DLGAP1 is not a classical drug target, thus no direct mechanism of drug action is described

03

Biological functions

Organization of postsynaptic densityProtein-protein interaction/adaptorSynaptic signalingRegulation of protein localization to synapseAggresome assemblyRegulation of proteasomal protein catabolic process
04

Disease associations

Neuropsychiatric disease (schizophrenia, autism spectrum disorder, obsessive-compulsive disorder)Retinitis pigmentosa (less common association)
05

Safety considerations

None known specifically related to pharmacological targeting; disruptions lead to altered neural synapse function and may contribute to neuropsychiatric phenotypes
06

Biomarkers

None established for therapy selection, but genetic variants in DLGAP1 have been associated with risk for OCD, ASD, and schizophrenia in GWAS and association studies

Beyond the preview

Go deeper on Disks large-associated protein 1 (DLGAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disks large-associated protein 1 (DLGAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call